Diabetes Complications: Clinical Trials

207 trials for Diabetes Complications, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

112 completed, 39 unknown, 21 recruiting, 15 terminated. 207 Phase 1, 90 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 1207Completed 112, Unknown 39, Recruiting 21, Terminated 15, Active not recruiting 7, Not yet recruiting 6, Withdrawn 5, Enrolling by invitation 1, Suspended 1
Phase 290Completed 42, Unknown 21, Recruiting 10, Terminated 7, Not yet recruiting 5, Withdrawn 3, Active not recruiting 2

Follow Diabetes Complications: new trials by email Literature Review of Diabetes Complications trials Research Report on Diabetes Complications

Trials (filtered) newest first · largest first

All 207 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Placental Cells for Diabetic Foot Ulcers
Placenta Stem Cells - Diabetic Foot Ulcer
Phase 1Not yet recruitingWake Forest University Health Sciences122027-03-012026-10-23
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of PAL-119 in Healthy Volunteers and Adult Participants With Type 1 or Type 2 Diabetes
PAL-119, Placebo - Healthy Volunteers and Diabetes Participants
Phase 1 / Phase 2Not yet recruitingPaulex Bio Inc.1472026-11-012026-10-28
Mesenchymal Stem Cells for Chronic Kidney Diseases
0.9% sodium chloride, MSCs - Kidney Disease, Chronic, Diabetic Kidney Disease (DKD)
Phase 1 / Phase 2Not yet recruitingThe First Affiliated Hospital of Air Force Medical University322026-11-012026-11-16
Evaluating Autologous Platelet-Rich Fibrin Plasma for Chronic Diabetic Foot Ulcers
PRFM, Standard of Care (SoC) - Diabetic Foot Ulcer (DFU), Ulcer
Phase 1 / Phase 2Not yet recruitingTiger Biosciences, LLC.552026-09-012026-09-25
Standard Treatment Associated With Phage Therapy Versus Placebo for Diabetic Foot Ulcers Infected by S. Aureus
Topical anti-Staphylococcus bacteriophage therapy, Topical placebo corresponding to anti-Staphylococcus bacteriophage therapy - Diabetic Foot, Staphylococcal Infections
Phase 1 / Phase 2Not yet recruitingCentre Hospitalier Universitaire de Nīmes602026-09-012026-03-20
Intranasal Delivery of Octreotide for Treatment of Diabetic Macular Edema
Octreotide (drug), Placebo - Diabetic Macular Edema
Phase 1WithdrawnUniversity of Alabama at Birmingham2026-08-312026-10-13
Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cell Therapy in Diabetic Nephropathy Patients: A Clinical Trial
Umbilical Cord Mesenchymal Stem Cells - Diabetic Nephropathy Type 2
Phase 1 / Phase 2RecruitingPT. Prodia Stem Cell Indonesia102026-07-012026-02-09
A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of RO7663498 Following Intravitreal Administration in Participants With Diabetic Retinopathy
RO7663498 - Diabetic Retinopathy
Phase 1RecruitingHoffmann-La Roche302026-06-182026-11-09
Controlled Trial to Evaluate the Safety and Efficacy of CYWC628 (Human Dermal Fibroblast Spheroids) for the Treatment of Refractory Diabetic Foot Ulcers Compared With Standard of Care
Standard of Care (SOC), SoC + Low dose CYWC628, SoC + High dose CYWC628 - Diabetic Foot Ulcer (DFU)
Phase 1 / Phase 2RecruitingFibroBiologics1202026-06-012026-08-26
Evaluation of MTX-439 in Healthy Adults and Adults With Diabetic Kidney Disease
MTX-439, Placebo - Healthy Adult Participants, Diabetic Kidney Disease
Phase 1RecruitingMediar Therapeutics882026-05-192026-06-29
Cannabidiol for the Treatment of Diabetic Peripheral Neuropathy: Pilot Study
Cannabidiol (CBD) oral solution, Full-Spectrum CBD hemp extract oral solution, Placebo in MCT oil oral solution - Diabetic Peripheral Neuropathic Pain (DPN), Diabetic Neuropathies
Phase 1 / Phase 2RecruitingFlorida A&M University202026-04-022026-04-29
Human Umbilical Cord Mesenchymal Stem Cell Injection for Diabetic Nephropathy
UC-MSCs, Placebo - Diabetic Nephropathy
Phase 1RecruitingTongji Hospital152026-03-252026-09-16
Phase 1 Study of VELGRAFT, a Living Cellular Construct, in the Management of Chronic Diabetic Foot Ulcers Which Have Attained Granulation Tissue
an allogenic cell-based product, containing living human bone marrow-derived mesenchymal stem cells (MSCs) and MSCs differentiated into adipocytes on a porous chitosan-gelatin matrix, Standard of Care of Diabetic Foot Ulcers - Diabetic Foot Ulcer (DFU), Granulation of Chronic Diabetic Wounds
Phase 1RecruitingAyu, Inc.242026-03-112026-09-02
Phase 1 Trial of Arginine Hydrochloride for the Management of Diabetic Ketoacidosis in Type 2 Diabetes
Arginine hydrochloride, Sodium Chloride 0.9% - Diabetes (DM), Diabetic Ketoacidosis
Phase 1 / Phase 2RecruitingDavid K Carroll602025-12-192026-02-12
Evaluation of ELU42 Topical Spray for the Treatment of Diabetic Foot Ulcers
ELU42 Topical Spray - Diabetic Foot Ulcer, Wagner Grade 1 - 2
Phase 1 / Phase 2RecruitingEluciderm Inc152025-11-102026-02-12
Air-Dried Human Amniotic Membrane Terminally Sterilized by Gamma Irradiation for Multidisciplinary Clinical Application
Air-Dried Human Amniotic Membrane (AD-hAM) - Diabetic Foot Ulcer (DFU), Ocular Disorder
Phase 1Active not recruitingLibyan Center for Biotechnology Research22025-11-012026-06-29
CGM-Guided Acarbose for Painful Diabetic Neuropathy
Acarbose 50 mg, Placebo - Diabetes, Diabetes Complications
Phase 1CompletedShifa International Hospital1702025-09-012026-03-03
Safety and Preliminary Efficacy of TrophiPatch, an Adipose-Derived Stromal Cell Patch for Chronic Leg Ulcers
TrophiPatch: allogeneic adipose-derived stromal cell patch - Diabetic Foot Ulcer (DFU), Venous Leg Ulcer (VLU)
Phase 1 / Phase 2RecruitingNicolò Brembilla182025-07-012025-07-02
A Study to Investigate Safety, Tolerability, PK, and PD of AZD4248 in Healthy Participants, Participants With CKD and Type 2 Diabetes, Assess Home Measurements of Creatinine in a Non-Interventional Cohort, and Assess the Effect of AZD4248 on the PK of Midazolam and Metformin in Healthy Participants
AZD4248, Placebo, Midazolam - Chronic Kidney Disease
Phase 1RecruitingAstraZeneca1922025-06-092026-11-12
Effect of Feldenkrais Method in Enhancing Postural Control for Patients with Diabetic Polyneuropathy
The Feldenkrais-based intervention, conventional balance training program - Diabetic Polyneuropathy
Phase 1Enrolling by invitationCairo University242025-03-302025-04-01

Showing 20 of 207. Sign in to see all of them.

Narrower conditions

Diabetic Foot (85)  ·  Diabetic Retinopathy (48)  ·  Diabetes Mellitus (44)  ·  Diabetic Nephropathies (38)  ·  Diabetic Neuropathies (26)  ·  Diabetes Mellitus, Type 1 (12)  ·  Diabetes Mellitus, Type 2 (11)  ·  Foot Ulcer (9)  ·  Macular Edema (9)  ·  Kidney Diseases (8)  ·  Renal Insufficiency, Chronic (8)  ·  Macular Degeneration (7)  ·  Peripheral Vascular Diseases (7)  ·  Retinal Diseases (7)

Broader conditions

Endocrine System Diseases (205)  ·  Diabetes Mellitus (163)  ·  Cardiovascular Diseases (136)  ·  Vascular Diseases (134)  ·  Diabetic Angiopathies (132)  ·  Skin and Connective Tissue Diseases (87)  ·  Diabetic Neuropathies (85)  ·  Skin Diseases (85)  ·  Skin Ulcer (83)  ·  Leg Ulcer (82)  ·  Foot Ulcer (76)  ·  Glucose Metabolism Disorders (55)  ·  Nutritional and Metabolic Diseases (55)  ·  Metabolic Diseases (54)

Interventions

Standard of Care (11)  ·  Sodium Chloride (6)  ·  Triamcinolone Acetonide (5)  ·  Ranibizumab (4)  ·  Drug Evaluation (3)  ·  Iohexol (3)  ·  Metformin (3)  ·  Saline Solution (3)  ·  p-Aminohippuric Acid (3)  ·  Bevacizumab (2)  ·  Injections (2)  ·  Laser Therapy (2)  ·  Lidocaine (2)  ·  Sirolimus (2)  ·  aflibercept (2)

Sponsors

National Eye Institute (NEI) (5)  ·  Boehringer Ingelheim (4)  ·  University of Sao Paulo (4)  ·  Jie Shen (3)  ·  University of Colorado, Denver (3)  ·  GL Pharm Tech Corporation (2)  ·  Goldfinch Bio, Inc. (2)  ·  Hadassah Medical Organization (2)  ·  Hanan Jafar (2)  ·  Heidelberg University (2)  ·  NOxy Health Products, LLC (2)  ·  National Taiwan University Hospital (2)  ·  Sheba Medical Center (2)  ·  South China Research Center for Stem Cell and Regenerative Medicine (2)  ·  Stratatech, a Mallinckrodt Company (2)

Countries

United States (85)  ·  China (16)  ·  Germany (10)  ·  Israel (10)  ·  United Kingdom (9)  ·  Australia (7)  ·  South Korea (7)  ·  Taiwan (6)  ·  Brazil (5)  ·  India (4)  ·  Iran (4)  ·  Spain (4)  ·  Denmark (3)  ·  Egypt (3)  ·  France (3)

Top investigators

Jie Shen (3)  ·  Masaomi Nangaku, Professor (2)  ·  Min-Gul Kim, Ph.D. (2)  ·  Petter Bjornstad, MD (2)  ·  Wei-Li Chen, MD, PhD (2)  ·  Abdalla Awidi, MD (1)  ·  Abdallah Awidi, MD (1)  ·  Albert Sotto, MD, PhD (1)  ·  Alireza Goodarzi, MSc (1)  ·  Allan H Ropper, M.D. (1)  ·  Aman Shah Abdul Majid, Ph.D. (1)  ·  Ambarish Pandey, MD, MSCS (1)

Results publications

PMID 17342504, PMID 19211094, PMID 20579630, PMID 21185118, PMID 21567211, PMID 22289660, PMID 22446172, PMID 22457045, PMID 22961573, PMID 23639598, PMID 25272318, PMID 25491299, PMID 26054585, PMID 27743903, PMID 28133924, PMID 29631615, PMID 29854007, PMID 30825073, PMID 30917698, PMID 32737116, PMID 33011075, PMID 33407796, PMID 33504262, PMID 34052927, PMID 34218718, PMID 34398099, PMID 34586227, PMID 35507146, PMID 35978329, PMID 36064604, PMID 36623423, PMID 37395169, PMID 37560967, PMID 37783947, PMID 38497241, PMID 39727944, PMID 39727950, PMID 39727989, PMID 39740667, PMID 39838970, PMID 39852146, PMID 40009460, PMID 40333016, PMID 40695570, PMID 41141513, PMID 41708511, PMID 41805697, PMID 42246764

NIH funding

2015 (2), 2016 (2), 2018 (2), 2019 (2), 2005 (1), 2008 (1), 2014 (1), 2017 (1), K23HL159292 (1), R01DK063017 (1), R01DK126837 (1), R01EY031315 (1), R43DK088634 (1), R44AR046154 (1), R44DK069924 (1)